PCOS and GLP-1 RA’s

GLP-1 receptor agonists (GLP-1 RAs) have shown benefit for individuals with polycystic ovarian syndrome (PCOS) due to their effects on weight management, insulin resistance, and metabolic health, which are common issues in PCOS.  Here’s how they relate: